First National Trust Co Sells 4,206 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

First National Trust Co reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 44,194 shares of the healthcare conglomerate’s stock after selling 4,206 shares during the quarter. UnitedHealth Group makes up approximately 1.0% of First National Trust Co’s investment portfolio, making the stock its 18th biggest position. First National Trust Co’s holdings in UnitedHealth Group were worth $23,267,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Wellington Management Group LLP grew its holdings in UnitedHealth Group by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after buying an additional 527,526 shares in the last quarter. Northern Trust Corp raised its stake in UnitedHealth Group by 3.6% during the third quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock valued at $4,934,895,000 after purchasing an additional 341,749 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of UnitedHealth Group by 2.2% during the third quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock valued at $4,155,676,000 after buying an additional 180,331 shares during the period. Charles Schwab Investment Management Inc. increased its position in shares of UnitedHealth Group by 0.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock worth $2,937,976,000 after acquiring an additional 27,127 shares during the period. Finally, Sanders Capital LLC boosted its holdings in shares of UnitedHealth Group by 6.5% in the third quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock valued at $2,902,829,000 after purchasing an additional 352,710 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $0.52 during trading hours on Friday, hitting $492.45. 2,487,811 shares of the stock traded hands, compared to its average volume of 5,130,659. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The stock has a market capitalization of $453.09 billion, a price-to-earnings ratio of 30.10, a P/E/G ratio of 1.43 and a beta of 0.55. The firm’s 50 day moving average price is $482.32 and its 200-day moving average price is $512.76.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period last year, the firm posted $6.26 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Stephens reissued an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 8th. Barclays boosted their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Bank of America reiterated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, Piper Sandler raised their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.